Abdominal apoplexy is a clinical entity characterized by spontaneous intraperitoneal hemorrhage from rupture of a visceral vessel. We describe a 34-year-old man who presented with abdominal apoplexy due to rupture of an ileocolic aneurysm. Subsequent biochemical and genetic analysis confirmed the diagnosis of Ehlers-Danlos syndrome type IV based on abnormal production of type III procollagen and a novel mutation in the COL3A1 gene. Patients presenting with abdominal apoplexy should undergo a thorough examination so that the underlying vascular pathology can be identified.
H istorically, the term abdominal apoplexy has been used to describe the clinical circumstance of massive, spontaneous intra-abdominal hemorrhage due to rupture of a visceral artery. This morbid event is characterized by acute onset of abdominal pain, followed by either immediate or delayed hemodynamic collapse. [1] [2] [3] Nearly all splanchnic arteries have been implicated as the cause of this catastrophic event, although in as many as one fourth of cases no specific source of hemorrhage is ever identified. 2 We report a case of abdominal apoplexy due to rupture of an ileocolic artery aneurysm in a patient with EhlersDanlos syndrome (EDS) type IV and a novel mutation of the type III procollagen gene COL3A1.
REPORT OF A CASE
A 34-year-old previously healthy man presented with a 2-day history of pain in his abdomen and right flank. Abdominal computed tomography with intravenous contrast revealed a large, right-sided retroperitoneal hematoma near a contrast-enhancing structure resembling a mesenteric artery aneurysm (Figure 1 ). The initial episode of abdominal pain resolved, and he was admitted for further work-up. On the following day, the patient experienced severe abdominal and flank pain associated with hypotension. While fluid resuscitation was administered and blood pressure normalized, emergency mesenteric arteriography showed a saccular aneurysm of the ileocolic artery with a patent arterial segment beyond the aneurysm (Figure 2 ). In addition, arteriography showed segmental occlusion of both the celiac and the superior mesenteric arteries beyond their respective origins. Because embolization would have required occluding the proximal main superior mesenteric artery, we elected to proceed with immediate surgical exploration.
Laparotomy disclosed massive hemoperitoneum emanating from the mesentery of the right colon. Further exploration revealed contained rupture of a 1.5-cm ileocolic artery aneurysm. The artery proximal and distal to the aneurysm was ligated, and the aneurysm was excised. The bowel was well perfused distal to the ligation as a result of collateral circulation. A second laparotomy 24 hours later revealed no evidence of bowel ischemia. The patient had an uncomplicated postoperative course and was discharged from the hospital.
After surgery, a detailed clinical examination was performed. The patient had features of generalized connective tissue laxity, including extremely soft ear cartilages, a long vertical face with a narrow jaw, an asthenic build, mild skin hyperelasticity, and joint hypermobility. He related no history of unusual bruising or abnormal scar formation and had no classic "cigarette paper" scars on examination. A transesophageal echocardiogram showed that the aortic annulus was mildly dilated at the upper limit of normal (25 mm). There was trivial central aortic regurgitation; the other cardiac valves were normal.
Gross pathologic and light microscopic examination of the artery revealed no calcification with nonspecific abnormalities. In considering the diagnosis of EDS type IV, a skin biopsy was performed for collagen analysis in cultured fibroblasts, which showed a decrease in the amount of type III procollagen molecules secreted by the cells, approximately 10% of normal. In addition, there was abnormal intracellular retention of type III procollagen molecules, the chains of which had markedly slow electrophoretic mobility. Molecular studies of the COL3A1 coding region identified a point mutation (A for G) at nucleotide 1358 (with reference to A of the initiating ATG as +1) in exon 21 of a COL3A1 allele. This resulted in substitution of aspartic acid for glycine at amino acid 286 within the triple helical region of the proα1(III) chain of type III procollagen.
These findings were consistent with the diagnosis of EDS type IV, the vascular or Sack-Barabas form.
DISCUSSION
EDS is a heterogeneous group of heritable connective tissue disorders. In the past, more than 10 "types" of EDS have been proposed (numerical classification, types I-X); however, recently an attempt was made to integrate the clinical, biochemical, and molecular genetic studies to provide a more descriptive classification. According to this newer classification, there are 7 EDS types, and EDS type IV is now referred to as vascular type EDS. 4 All forms of the syndrome can cause medical problems as a result of skin hyperextensibility, joint hypermobility, and tissue fragility, but only individuals with EDS type IV are at risk for arterial dissections or rupture, gastrointestinal perforations, and uterine rupture during pregnancy. 5 EDS type IV results from mutations in the COL3A1 gene that encodes the constitutive chains of type III procollagen, a major component of blood vessels, bowel, skin, and hollow organs. It is an autosomal dominant disorder that is considered an uncommon condition, although the precise incidence is unknown. 5 The presence of 2 or more of the major diagnostic criteria (arterial rupture, intestinal rupture, uterine rupture during pregnancy, and a family history of EDS type IV) makes the diagnosis of EDS type IV highly likely and warrants biochemical or genetic testing for confirmation. 5 Type III procollagen molecules are composed of 3 identical proα1(III) chains (homotrimers). Each proα1(III) chain contains 3 domains, the N-terminal domain (Npropeptide), the collagen domain (main triple helix, composed of 343 Gly-Xaa-Yaa repeats), and the C-terminal domain (C-propeptide). About two thirds of mutations in the COL3A1 gene result in substitutions for glycine residues in the triple helical domain of the protein, and the majority of the remainder are exon-skipping mutations. At present there is a lack of a phenotype-genotype correlation because there is no clear association between the nature and location of the mutation in the gene and the type and timing of complications in patients with the EDS type IV phenotype. 5 As a consequence of the genetic defect in EDS type IV, normal type III collagen is reduced or absent within the tunica media of large elastic arteries. This results in a decrease in the tensile strength of the arteries and a predisposition to vascular abnormalities, such as true and false aneurysms, spontaneous ruptures, dissections, and arteriovenous fistulas in all major vessels of the body. 6 Despite the increasing experience with the clinical and genetic diagnosis of this disease, there have been only 10 reported cases of visceral artery aneurysms in patients with EDS type IV. 7 Of the 10 patients, 8 were asymptomatic, and 2 presented with acute irreversible hemorrhage resulting in death. In the cases reported to date, aneurysms have been described in the celiac, hepatic, splenic, superior mesenteric, renal, and pancreatoduodenal arteries. 7 The patient described in this report is, to our knowledge, the first to have genetically confirmed EDS type IV and a documented ileocolic artery aneurysm that was symptomatic. Furthermore, a review of the International Collagen Gene Database 8, 9 showed that the mutation identified in exon 21 of the COL3A1 gene in this patient has not been described previously.
In 1937, Bruce proposed that abdominal apoplexy in young patients might be due to rupture of a mesenteric artery as a result of a structural defect in the vessel wall. 1 Since then, the literature contains many reports 1-3,10,11 attributing an uncharacterized vessel wall abnormality as the cause of abdominal apoplexy in young persons. Although arteriosclerosis and hypertension are potential predisposing factors in older patients, they cannot be incriminated as a cause in young healthy patients. However, given the fact that 80% of patients with EDS type IV develop a major complication by the age of 40 years, half of which being arterial in nature 5 and potentially fatal, it is possible that this syndrome was responsible for the spontaneous arterial rupture of visceral vessels in some of the previously reported young patients with abdominal apoplexy.
Patients with abdominal apoplexy present in an acute clinical setting with nonspecific findings; therefore, the diagnosis of abdominal apoplexy requires a high index of suspicion. 1, 12 Urgent or emergency operation with identification and ligation of the bleeding artery is essential for survival of patients with abdominal apoplexy.
2 Surgical reconstruction in patients with EDS type IV is hazardous because of the extremely friable nature of the vessels, which precludes the use of standard suture techniques. Therefore, bleeding visceral arteries in patients with EDS type IV should be managed by proximal and distal ligation, with a bypass graft attempted only if the degree of ischemia requires revascularization. 7 In newly diagnosed patients with EDS type IV, a thorough family history with attention to early and/or unexplained deaths helps to determine whether this represents an inherited condition and to identify other members at risk. All first-degree relatives of affected patients should be examined for signs of the syndrome, although approximately 40% of EDS type IV cases are thought to result from de novo mutations. 5 As a result of the autosomal dominant mode of inheritance, the offspring of the index patient and other at-risk family members should be tested by biochemical analysis of type III procollagen synthesis in cultured skin fibroblasts.
In young people who present with unexplained arterial catastrophes such as abdominal apoplexy, EDS type IV should be considered. The diagnosis should then be confirmed by examining the biosynthesis of type III procollagen in cultured dermal fibroblasts or sequences of the COL3A1 gene. Timely recognition of this condition is necessary because patients with EDS type IV are at increased risk for premature death as a result of arterial, bowel, and uterine rupture in pregnant women (median life expectancy, 48 years). No specific treatment is known to increase the production of normal type III collagen or delay the onset of complications in patients with EDS type IV. Reasonable prophylactic measures include avoidance of highimpact activities and regular use of stool softeners and high-fiber diets to lessen the chance of intestinal rupture. Women of childbearing age should be counseled that pregnancy carries an 11% mortality rate and that their offspring have a 50% chance of being affected. The key element in the clinical management of these patients is awareness of this condition along with recognition of major complications and appropriate planning of surgical procedures and pregnancy in female patients. 
